Publications by authors named "Nirav Parikh"
Article Synopsis
- The study investigates the effectiveness of the Vasoactive-ventilation-renal (VVR) score in predicting early postoperative outcomes for adults undergoing mitral valve surgery.
- Conducted on 100 patients, it monitored various preoperative and postoperative variables, including vasoactive-inotropic score and Ambler score, to analyze ICU and hospital stay lengths and mortality rates.
- Findings suggest that the VVR score, particularly at 48 hours post-surgery, is a valuable predictor for early outcomes after the procedure.
Effect of Goal-directed Hemodynamic Therapy in Postcardiac Surgery Patients.
Indian J Crit Care Med
May 2020
Background And Aims: Early goal-directed therapy (EGDT) provides preset goals to be achieved by intravenous fluid therapy and inotropic therapy with earliest detection of change in the hemodynamic profile. Improved outcome in cardiac surgery patients has been shown by perioperative volume optimization, while postoperative intensive care unit (ICU) stay can be decreased by improving oxygen delivery. Our aim of this study was to study the outcome of EGDT in patients undergoing elective cardiac surgery.
View Article and Find Full Text PDFPatient perceptions and acceptance of routine emergency department HIV testing.
Public Health Rep
February 2009
Objectives: We report on the rates of patient acceptance and their perceptions of routine emergency department (ED) human immunodeficiency virus (HIV) testing in a high-prevalence area.
Methods: We analyzed the race/ethnicity of patients who either accepted or declined a routine HIV test that was offered to all patients in the ED of a large academic center. We also distributed a patient perception survey about ED HIV testing.
Purpose: To evaluate the visual and anatomical outcomes of intravitreal bevacizumab (Avastin; Genentech, Inc., South San Francisco, CA) treatment of choroidal neovascularization (CNV) in patients with angioid streaks (ASs).
Methods: A 44-year-old man with angioid streaks and CNV in both eyes (best-corrected visual acuity: 20/400, right eye; 20/50, left eye) received intravitreal bevacizumab injections at monthly intervals.